State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, People's Republic of China
Indian J Ophthalmol. 2012 Sep-Oct;60(5):428-31. doi: 10.4103/0301-4738.100542.
Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world's health systems. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and we estimate that the number with vision-threatening diabetic retinopathy (VTDR) will increase from 37.3 million to 56.3 million, if prompt action is not taken. Despite growing evidence documenting the effectiveness of routine DR screening and early treatment, DR frequently leads to poor visual functioning and represents the leading cause of blindness in working-age populations. DR has been neglected in health-care research and planning in many low-income countries, where access to trained eye-care professionals and tertiary eye-care services may be inadequate. Demand for, as well as, supply of services may be a problem. Rates of compliance with diabetes medications and annual eye examinations may be low, the reasons for which are multifactorial. Innovative and comprehensive approaches are needed to reduce the risk of vision loss by prompt diagnosis and early treatment of VTDR.
糖尿病视网膜病变（DR）是糖尿病的一种主要微血管并发症，对全球卫生系统有重大影响。在全球范围内，DR 患者人数将从 2010 年的 1.266 亿增加到 2030 年的 19.1 亿，如果不采取及时行动，预计有威胁视力的糖尿病视网膜病变（VTDR）患者人数将从 3730 万增加到 5630 万。尽管越来越多的证据证明常规 DR 筛查和早期治疗的有效性，但 DR 仍经常导致视力不佳，是工作年龄人群失明的主要原因。在许多低收入国家，DR 在卫生保健研究和规划中被忽视，这些国家可能缺乏训练有素的眼科保健专业人员和三级眼科保健服务。对服务的需求和供应可能是一个问题。遵守糖尿病药物治疗和每年进行眼部检查的比率可能较低，其原因是多方面的。需要采取创新和全面的方法，通过及时诊断和早期治疗 VTDR 来降低视力丧失的风险。
